NextCure Drops 57%, Falling Back to Earth After Positive Data for New Cancer Treatment

(Bloomberg) -- NextCure plunged 57% in pre-market trading Monday, peeling back gains last week that drove shares to more than triple after positive early data for a new cancer treatment, NC318. The...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.